Stockreport

Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF - Each shareholder is estimated to receive US$1.82 per share plus one CVR per common share -- Transaction expected to close in the first quarter of 2026 -- Additional po [Read more]